Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $971 | $882 | $776 | $827 |
| - Cash | $54 | $48 | $34 | $33 |
| + Debt | $20 | $21 | $18 | $15 |
| Enterprise Value | $937 | $854 | $760 | $810 |
| Revenue | $53 | $51 | $49 | $48 |
| % Growth | 3.5% | 3.5% | 2.9% | – |
| Gross Profit | $37 | $35 | $33 | $32 |
| % Margin | 69% | 68.1% | 67.7% | 66.3% |
| EBITDA | $2 | $6 | $6 | $2 |
| % Margin | 3% | 11.6% | 11.3% | 3.2% |
| Net Income | $0 | $1 | $2 | -$1 |
| % Margin | 0.2% | 2.8% | 3.7% | -1.1% |
| EPS Diluted | 0.001 | 0.015 | 0.014 | -0.006 |
| % Growth | -94.1% | 7% | 336.7% | – |
| Operating Cash Flow | $10 | $16 | $7 | $2 |
| Capital Expenditures | -$3 | -$3 | -$3 | -$3 |
| Free Cash Flow | $7 | $13 | $5 | -$1 |